Rabbit Anti-Goat IgG H&L (HRP) (ab6741)
Key features and details
- Rabbit Anti-Goat IgG H&L (HRP)
- Conjugation: HRP
- Host species: Rabbit
- Isotype: IgG
- Suitable for: Dot blot, ELISA, IHC-P, IHC-Fr, Immunomicroscopy, ICC/IF, WB
Related conjugates and formulations
Overview
-
Product name
Rabbit Anti-Goat IgG H&L (HRP)
See all IgG secondary antibodies -
Host species
Rabbit -
Target species
Goat -
Tested applications
Suitable for: Dot blot, ELISA, IHC-P, IHC-Fr, Immunomicroscopy, ICC/IF, WBmore details -
Immunogen
Goat IgG whole molecule
-
Conjugation
HRP
Properties
-
Form
Liquid -
Storage instructions
Shipped at 4°C. Store at +4°C. -
Storage buffer
pH: 6.50
Preservative: 0.01% Gentamicin sulphate
Constituents: 0.42% Tripotassium orthophosphate, 0.87% Sodium chloride, 1% BSA -
Concentration information loading...
-
Purity
Affinity purified -
Purification notes
This product was prepared from monospecific antiserum by immunoaffinity chromatography using Goat IgG coupled to agarose beads followed by solid phase adsorption(s) to remove any unwanted reactivities. -
Conjugation notes
Horseradish Peroxidase (HRP) -
Clonality
Polyclonal -
Isotype
IgG -
Research areas
Associated products
-
Substrate reagent
- TMB ELISA Substrate (Highest Sensitivity) (ab171522)
- TMB ELISA Substrate (High Sensitivity) (ab171523)
- TMB ELISA Substrate (Fast Kinetic Rate) (ab171524)
- TMB ELISA Substrate (Slow Kinetic Rate) (ab171525)
- TMB ELISA Substrate (Slower Kinetic Rate) (ab171526)
- TMB ELISA Substrate (Slowest Kinetic Rate) (ab171527)
Applications
The Abpromise guarantee
Our Abpromise guarantee covers the use of ab6741 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Application | Abreviews | Notes |
---|---|---|
Dot blot |
Use at an assay dependent concentration.
|
|
ELISA |
1/50000 - 1/100000.
|
|
IHC-P | (1) |
Use at an assay dependent concentration.
|
IHC-Fr | (1) |
Use at an assay dependent concentration.
|
Immunomicroscopy |
Use at an assay dependent concentration.
|
|
ICC/IF |
1/1000 - 1/5000.
|
|
WB | (1) |
1/5000 - 1/20000. PubMed: 17369188
|
Notes |
---|
Dot blot
Use at an assay dependent concentration. |
ELISA
1/50000 - 1/100000. |
IHC-P
Use at an assay dependent concentration. |
IHC-Fr
Use at an assay dependent concentration. |
Immunomicroscopy
Use at an assay dependent concentration. |
ICC/IF
1/1000 - 1/5000. |
WB
1/5000 - 1/20000. PubMed: 17369188 |
Images
Protocols
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
Datasheets and documents
-
Datasheet download
References (213)
ab6741 has been referenced in 213 publications.
- Ha MY et al. In-situ forming injectable GFOGER-conjugated BMSCs-laden hydrogels for osteochondral regeneration. NPJ Regen Med 8:2 (2023). PubMed: 36609447
- Yu D et al. Structural mechanism of BRD4-NUT and p300 bipartite interaction in propagating aberrant gene transcription in chromatin in NUT carcinoma. Nat Commun 14:378 (2023). PubMed: 36690674
- Que D et al. ACSS2-mediated NF-κB activation promotes alkaliptosis in human pancreatic cancer cells. Sci Rep 13:1483 (2023). PubMed: 36707625
- Ganesan S et al. Syntaxin 11 Contributes to the Interferon-Inducible Restriction of Coxiella burnetii Intracellular Infection. mBio 14:e0354522 (2023). PubMed: 36728431
- Coleman KL et al. Phosphorylation of IGFBP-3 by Casein Kinase 2 Blocks Its Interaction with Hyaluronan, Enabling HA-CD44 Signaling Leading to Increased NSCLC Cell Survival and Cisplatin Resistance. Cells 12:N/A (2023). PubMed: 36766747